Clinical Trial Update: Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of concomitant Mansonella perstans microfilaremia on immune responses after a single-dose praziquantel in schisto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Praziquantel (Praziquantel)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Schistosomiasis | Phase 4 | Status: WITHDRAWN